Balyasny Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-11,278
| Closed | -$56.3K | – | 1977 |
|
2024
Q4 | $56.3K | Buy |
+11,278
| New | +$56.3K | ﹤0.01% | 1838 |
|
2024
Q1 | – | Sell |
-18,720
| Closed | -$65.7K | – | 1948 |
|
2023
Q4 | $65.7K | Sell |
18,720
-48,860
| -72% | -$171K | ﹤0.01% | 1831 |
|
2023
Q3 | $451K | Buy |
67,580
+52,725
| +355% | +$352K | ﹤0.01% | 1337 |
|
2023
Q2 | $125K | Sell |
14,855
-11,624
| -44% | -$97.5K | ﹤0.01% | 1708 |
|
2023
Q1 | $263K | Sell |
26,479
-4,641
| -15% | -$46.1K | ﹤0.01% | 1730 |
|
2022
Q4 | $217K | Buy |
+31,120
| New | +$217K | ﹤0.01% | 1672 |
|
2021
Q2 | – | Sell |
-11,964
| Closed | -$142K | – | 1647 |
|
2021
Q1 | $142K | Buy |
+11,964
| New | +$142K | ﹤0.01% | 1420 |
|